Dan Staner

Dan Staner serves as the Chief Business Officer at ALCEDIAG, leading the global commercialization of the innovative RNA diagnostic test, Edit-B, for bipolar disorder and major depressive disorder. Prior to ALCEDIAG, Staner was Vice President and General Manager for Germany and Switzerland at Moderna, overseeing the market transition from pandemic to endemic and facilitating the launch of new products. With extensive experience at Eli Lilly and Company, Staner held various leadership roles across multiple regions, including Middle East, Pakistan, Europe, and South Asia, focusing on marketing strategies, commercial execution, and organizational transformation. Staner holds an MSc in Economics and Business Management from HEC Lausanne and has completed executive education programs at prestigious institutions, including University of St.Gallen and INSEAD.